WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New ATC 5th levels

List of latest ATC/DDD decisions from the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the decisions should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline (see list). If no objections are received, the new ATC/DDD decisions will be considered final and included in the ATC/DDD Index. In the list final indicates that the date for objection has expired. The year of implementation in the ATC/DDD Index is given in the list.

Please note that the ATC and DDD alterations are only valid and implemented in the coming annual updates of January 1st.

ATC codeATC level nameDeadline for objection to temporary codesImplementation in ATC/DDD index
V10XA03iodine (131I) omburtamab01.09.20212022
V09IX14gallium (68Ga) PSMA-11Final2022
V09GX05ammonia (13N)Final2022
V03AX04difelikefalin01.09.20212022
V03AG05 sodium phosphate Final2022
V03AF12trilaciclibFinal2022
S01LA08bevacizumabFinal2022
S01GX13bilastine01.09.20212022
S01GX12cetirizineFinal2022
S01EX07ripasudilFinal2022
R06AA11dimenhydrinateFinal2022
R05DB29gefapixant01.09.20212022
R03DX11tezepelumabFinal2022
R03CC15formoterol01.09.20212022
P03AX07abametapirFinal2022
P01BF09artesunate, sulfadoxine and pyrimethamineFinal2022
P01BF08 artemisinin and naphthoquineFinal2022
P01BF07artemisinin and piperaquineFinal2022
P01BB52chloroquine and proguanilFinal2022
P01AB52metronidazole and diloxanideFinal2022
P01AA30tilbroquinol and tiliquinolFinal2022
N07XX17arimoclomol01.09.20212022
N07XX16deutetrabenazineFinal2022
N06DX03aducanumabFinal2022
N06AX28levomilnacipran01.09.20212022
N05CM21lemborexantFinal2022
N05BA25mexazolam01.09.20212022
N05AD10lumateperoneFinal2022
N03AX27ganaxolone01.09.20212022
N02CD07atogepant01.09.20212022
N02CD06rimegepantFinal2022
N02CD05eptinezumabFinal2022
N02CD04ubrogepantFinal2022
N02CC08lasmiditanFinal2022
N02BG12tanezumabFinal2022
N02AX51tilidine and naloxoneFinal2022
N02AX07oliceridine01.09.20212022
N02AJ16tramadol and celecoxib 01.09.20212022
M09AX13casimersen01.09.20212022
M09AX12viltolarsenFinal2022
M05BX07vosoritideFinal2022
M02AA31loxoprofen01.09.20212022
L04AX09diroximel fumarateFinal2022
L04AC22spesolimab01.09.20212022
L04AC21bimekizumabFinal2022
L04AC20netakimabFinal2022
L04AA56deucravacitinib01.09.20212022
L04AA55sutimlimab 01.09.20212022
L04AA54pegcetacoplan01.09.20212022
L04AA53teprotumumabFinal2022
L04AA52ofatumumabFinal2022
L04AA51anifrolumabFinal2022
L04AA50ponesimodFinal2022
L04AA49peficitinibFinal2022
L04AA48belumosudilFinal2022
L03AB16peginterferon alfacon-201.09.20212022
L02BX04relugolix01.09.20212022
L01XX74belzutifan01.09.20212022
L01XX73sotorasibFinal2022
L01XX72tazemetostatFinal2022
L01XK06pamiparibFinal2022
L01XC42prolgolimabFinal2022
L01FX18amivantamab01.09.20212022
L01FX17sacituzumab govitecan01.09.20212022
L01FX16oportuzumab monatox 01.09.20212022
L01FF10retifanlimab01.09.20212022
L01FF09tislelizumab01.09.20212022
L01FD05trastuzumab duocarmazine01.09.20212022
L01EX23pralsetinibFinal2022
L01EX22selpercatinibFinal2022
L01EN04futibatinib01.09.20212022
L01EN03infigratinib01.09.20212022
L01EJ03pacritinib01.09.20212022
L01EA06asciminibFinal2022
L01AA10melphalan flufenamide01.09.20212022
J07BX04dengue virus vaccines01.09.20212022
J07BX03covid-19 vaccinesFinal2022
J07AG54haemophilus influenza B, combinations with meningococcus C,Y, conjugatedFinal2022
J06BD03tixagevimab and cilgavimab01.09.20212022
J05AX31lenacapavir01.09.20212022
J05AP12coblopasvir01.09.20212022
J05AB17brincidofovir01.09.20212022
J05AB16remdesivirFinal2022
J02AC06oteseconazoleFinal2022
J01RA15cefixime and ornidazoleFinal2022
J01RA14norfloxacin and metronidazoleFinal2022
H01CC04linzagolix01.09.20212022
H01AC08somatrogon01.09.20212022
D11AX27oxymetazoline01.09.20212022
D11AH08abrocitinibFinal2022
D10AX06clascoteroneFinal2022
D03AX15traferminFinal2022
C10BA12pravastatin, ezetimibe and fenofibrate01.09.20212022
C10BA11pravastatin and ezetimibeFinal2022
C10AX18volanesorsenFinal2022
C10AX17evinacumabFinal2022
C08CA17levamlodipineFinal2022
C03DA05finerenone01.09.20212022
B06AX03voxelotorFinal2022
B06AC06berotralstatFinal2022
B03XA08vadadustatFinal2022
B03XA07daprodustatFinal2022
A16AX20lonafarnibFinal2022
A16AX19fosdenopterinFinal2022
A16AB22 avalglucosidase alfa 01.09.20212022
A16AB21atidarsagene autotemcel01.09.20212022
A16AB20pegunigalsidase alfaFinal2022
A10BX15imegliminFinal2022
A10BD27metformin, linagliptin and empagliflozinFinal2022
A08AA12setmelanotideFinal2022
A05AX05odevixibatFinal2022
A05AX04maralixibat chlorideFinal2022
A02BD16 omeprazole, amoxicillin and rifabutin01.09.20212022
A02BC09tegoprazanFinal2022

Last updated: 2021-05-04